Fasciola Hepatica Extract Induces Cell Death of Mammalian Cells
BACKGROUND: Fascioliasis is a neglected tropical disease that affects poor people from poor and developing countries. In the world, it has been estimated that at least 2.6 million people are affected with this disease. The International agency for Research on Cancer, states that O. viverrini and C. sinensis, also liver flukes, are considered as definitive causes of cholangiocarcinoma. However, fascioliasis caused by F. hepatica has not been associated with cancer to date. There are not any known causative associations between this parasite and liver cancer (cholangiocarcinoma).
METHODS: Chine Hamster Ovary (CHO) cells were treated with F. hepatica extracts and cell proliferation was assessed by using the indirect method for estimating cell number based on the mitochondrial activity with MTS cell proliferation reagent. We observed unexpected death of these cells when treated with F. hepatica extracts.
RESULTS: We now hypothesize that this parasite could be used as a medically-important trematode pathogen in cancer therapy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Anti-infective agents - 16(2018), 2 vom: 31., Seite 144-146 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ferreira, Stephanie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
C. sinensis |
|---|
| Anmerkungen: |
Date Revised 18.03.2022 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.2174/1570180815666180531102555 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM287188256 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM287188256 | ||
| 003 | DE-627 | ||
| 005 | 20231225053446.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1570180815666180531102555 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0957.xml |
| 035 | |a (DE-627)NLM287188256 | ||
| 035 | |a (NLM)30079296 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ferreira, Stephanie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Fasciola Hepatica Extract Induces Cell Death of Mammalian Cells |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 18.03.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a BACKGROUND: Fascioliasis is a neglected tropical disease that affects poor people from poor and developing countries. In the world, it has been estimated that at least 2.6 million people are affected with this disease. The International agency for Research on Cancer, states that O. viverrini and C. sinensis, also liver flukes, are considered as definitive causes of cholangiocarcinoma. However, fascioliasis caused by F. hepatica has not been associated with cancer to date. There are not any known causative associations between this parasite and liver cancer (cholangiocarcinoma) | ||
| 520 | |a METHODS: Chine Hamster Ovary (CHO) cells were treated with F. hepatica extracts and cell proliferation was assessed by using the indirect method for estimating cell number based on the mitochondrial activity with MTS cell proliferation reagent. We observed unexpected death of these cells when treated with F. hepatica extracts | ||
| 520 | |a RESULTS: We now hypothesize that this parasite could be used as a medically-important trematode pathogen in cancer therapy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a C. sinensis | |
| 650 | 4 | |a Chine Hamster Ovary (CHO) | |
| 650 | 4 | |a Fasciola hepatica | |
| 650 | 4 | |a O. viverrini | |
| 650 | 4 | |a cholangiocarcinoma | |
| 650 | 4 | |a mammalian cells | |
| 700 | 1 | |a Fernandes, Ruben |e verfasserin |4 aut | |
| 700 | 1 | |a Botelho, Monica C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anti-infective agents |d 2016 |g 16(2018), 2 vom: 31., Seite 144-146 |w (DE-627)NLM259494550 |x 2211-3525 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2018 |g number:2 |g day:31 |g pages:144-146 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1570180815666180531102555 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2018 |e 2 |b 31 |h 144-146 | ||